By Dr Claire Deakin

Journal articles

Deakin CT; Alexander IE; Hooker CA; Kerridge IH, 2013, 'Gene therapy researchers' assessments of risks and perceptions of risk acceptability in clinical trials', Molecular Therapy, 21, pp. 806 - 815, http://dx.doi.org/10.1038/mt.2012.230

Deakin CT; Alexander IE; Kerridge I, 2010, 'The ethics of gene therapy: Balancing the risks', Current Opinion in Molecular Therapeutics, 12, pp. 578 - 585

Deakin CT; Alexander IE; Kerridge I, 2009, 'Accepting risk in clinical research: Is the gene therapy field becoming too risk-averse?', Molecular Therapy, 17, pp. 1842 - 1848, http://dx.doi.org/10.1038/mt.2009.223

Bennett B; Deakin C, 2009, 'Registration of clinical trials: challenges for global regulation.', Journal of law and medicine, 17, pp. 82 - 94

Deakin C, 2008, 'Resolving the regulatory conflict: Lessons for Australia from the European experience of regulating the release of genetically modified organisms into the environment', Environmental and Planning Law Journal, 25, pp. 22 - 48

Smyth CM; Ginn SL; Deakin CT; Logan GJ; Alexander IE, 2007, 'Limiting γc expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors', Blood, 110, pp. 91 - 98, http://dx.doi.org/10.1182/blood-2006-11-055442

Back to profile page